Seòmar agus comataidhean

Creative Scotland has commissioned a review of fair work, leadership, workforce and skills development across the arts, screen and creative industries in Scotland. The review will take place between August 2021 and February 2022.

We announced the launch of the new Just Transition Commission and confirmed Professor Jim Skea as returning Chair on 15 September. Further announcements on the wider membership will be made in due course.

Our response to the previous Just Transition Commission’s report was published alongside Programme for Government and set out our ambitious agenda to achieve a fairer, greener future for all. We are determined to get this right for the people of Scotland, bringing all affected communities with us while learning from unjust transitions in our recent history.

The previous Commission called on the Scottish Government to pursue an orderly, managed transition through the creation of Just Transition Plans for high-emitting industries. In our response, we set out our approach to just transition planning across the Scottish economy and I want the new Commission to play a crucial role in this.

Our new Commission will be delivery focused. It will support (and scrutinise) the production and delivery of Scottish Government-led transition plans.

Specifically, the Commission will be tasked with:

• Providing scrutiny and advice on the ongoing development of Scotland’s Just Transition Plans, including the application of the planning framework, as they are developed;
• Advising on the most suitable approaches to monitoring and evaluation;
• Supporting the Scottish Government’s ambition to be a leader in the international community and to take decisions informed by international best practice;
• Meaningful engagement with those most likely to be impacted by the transition; hearing from a broad range of representative voices to help shape just transition planning in Scotland;
• Publishing an annual report to reflect on Scotland’s progress.

Scotland is the second country in the world, after New Zealand, with 100 per cent Fracture Liaison Service provision across all 14 Health Boards.

Our NHS Recovery Plan, published on 25 August, outlines that the Centre for Sustainable Delivery will work collaboratively with Health Boards, health and social care partners, third sector, academia and industry to identify and implement improvements to care pathways across Scotland. This will include extending new approaches to delivering care that minimise the requirement for patients to travel, and provide services more efficiently – for example virtual appointments and virtual fracture clinics.

1,020 applications were received under the Seafood Producers Resilience Fund. 911 applications were approved and paid a total of £5,808,112 with 109 applications declined.

The Scottish Government Chief Scientist Office (CSO) investment in NHS Research Scotland (NRS) clinical research infrastructure is supporting NHS Health Board participation in a number of COVID-19 vaccine trials to provide data for regulatory submissions for approval for use.

The CSO, NRS and health boards work closely with the UK Vaccines Taskforce to bring a range of vaccine trials to Scotland.

Regulatory approval and licensing conditions for the use of COVID-19 vaccines is a statutory responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).

More information about the trials being supported by NHS Research Scotland is available at: COVID-19 vaccine studies | NHS Research Scotland | NHS Research Scotland .

We are working across the Common Travel Area to ensure that the vaccination certification scheme recognises people who were vaccinated in other countries in the Common Travel Area with a Medicines & Healthcare products Regulatory Agency (MHRA) approved vaccine. We will put in place, before the scheme goes live, an interim process to enable Scottish residents who have had a dose outside Scotland to have their vaccine record updated. People will be able to get a record of their vaccination from whichever country they were vaccinated in – this will be accepted in Scotland for entry purposes.

Consultation on this matter took place prior to the announcement by the First Minister, and in line with the provisions of the cooperation agreement.

As no timeline has been specified by the member, information from 22 March 2021 to 22 September 2021 is provided. During this period, no meetings have taken place between Cabinet Secretaries or Ministers with representatives of CalaChem Ltd in Grangemouth. I last visited CalaChem as Minister for Trade, Investment and Innovation on 5 November 2019. The Scottish Government does not hold the information on Scottish Enterprise meetings with CalaChem Ltd centrally. However, I have requested that Scottish Enterprise respond to the member directly with this information.

Local authorities are independent corporate bodies with their own powers and responsibilities, separate from the Scottish Government. As such, the information requested is not held by the Scottish Government and would have to be obtained directly from individual local authorities or from COSLA.

I refer the member to the answer to question S6W-02513 on 21 September 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers